Applied Evidence

Is diabetes distress on your radar screen?

Author and Disclosure Information

Diabetes distress, which affects almost half of those with diabetes, contributes to worsening glycemic control. Recognizing and responding to it is essential.

PRACTICE RECOMMENDATIONS

› Educate patients about diabetes distress, explaining that diabetes is manageable and that neither complications nor diabetes distress is inevitable. C

› Empower patients to take an active role in self-management of diabetes, encouraging them to express their concerns and ask open-ended questions. A

› Support shared decision-making by inquiring about patients’ values and treatment preferences, presenting options, and reviewing the risks and benefits of each. C

Strength of recommendation (SOR)

A Good-quality patient-oriented evidence
B Inconsistent or limited-quality patient-oriented evidence
C Consensus, usual practice, opinion, disease-oriented evidence, case series


 

References

Managing diabetes is a complex undertaking, with an extensive regimen of self-care—including regular exercise, meal planning, blood glucose monitoring, medication scheduling, and multiple visits—that is critically linked to glycemic control and the prevention of complications. Incorporating all of these elements into daily life can be daunting.1-3

In fact, nearly half of US adults with diabetes fail to meet the recommended targets.4 This leads to frustration, which often manifests in psychosocial problems that further hamper efforts to manage the disease.5-10 The most notable is a psychosocial disorder known as diabetes distress, which affects close to 45% of those with diabetes.11,12

It is important to note that diabetes distress is not a psychiatric disorder;13 rather, it is a broad affective reaction to the stress of living with this chronic and complex disease.14,15 By negatively affecting adherence to a self-care regimen, diabetes distress contributes to worsening glycemic control and increasing morbidity.16-18

Recognizing that about 80% of those with diabetes are treated in primary care settings,19 we wrote this review to call your attention to diabetes distress, alert you to brief screening tools that can easily be incorporated into clinic visits, and offer guidance in matching proposed interventions to the aspects of diabetes self-management that cause patients the greatest distress.

Diabetes distress: What it is, what it’s not

For patients with type 2 diabetes, diabetes distress centers around 4 main issues:

  • frustration with the demands of self-care;
  • apprehension about the future and the possibility of developing serious complications;
  • concern about both the quality and the cost of required medical care; and
  • perceived lack of support from family and/or friends.11,12,20

As mentioned earlier, diabetes distress is not a psychiatric condition and should not be confused with major depressive disorder (MDD). Here’s help in telling the difference.

Unlike major depressive disorder, diabetes distress has a specific cause—diabetes—and can best be understood as an emotional response to a demanding health condition.

For starters, a diagnosis of depression is symptom-based.13 MDD requires the presence of at least 5 of the 9 symptoms defined by the Diagnostic and Statistical Manual of Mental Disorders, Fifth ed. (DSM-5)—eg, persistent feelings of worthlessness or guilt, sleep disturbances, lack of interest in normal activities—for at least 2 weeks.21 What’s more, the diagnostic criteria for MDD do not specify a cause or disease process. Nor do they distinguish between a pathological response and an expected reaction to a stressful life event.22 Further, depression measures reflect symptoms (eg, hyperglycemia), as well as stressful experiences resulting from diabetes self-care, which may contribute to the high rate of false positives or incorrect diagnoses of MDD and missed diagnoses of diabetes distress.23

Pages

Recommended Reading

Examining the safety of lipid-lowering drugs in pregnancy
MDedge Family Medicine
New guidelines provide standardized hypoglycemia values for clinical evaluation
MDedge Family Medicine
Empagliflozin first antidiabetes drug to gain cardioprotective indication
MDedge Family Medicine
Diabetes treatment costs doubled in Sweden since 2006
MDedge Family Medicine
Landmark psychosocial guidelines for diabetes spark debate over the ideal vs. the practical
MDedge Family Medicine
FDA affirms bladder cancer warning with diabetes drug
MDedge Family Medicine
XR version of Synjardy gets FDA’s nod
MDedge Family Medicine
FDA expands indication for continuous glucose monitoring system
MDedge Family Medicine
ADA: Empagliflozin and liraglutide reduce type 2 CV death
MDedge Family Medicine
Diabetes, ischemic heart disease, pain lead health spending
MDedge Family Medicine